Skip to main content
Erschienen in: World Journal of Surgery 3/2013

01.03.2013

Larynx-Preserving Limited Resection and Free Jejunal Graft For Carcinoma of the Cervical Esophagus

verfasst von: Hiroshi Miyata, Makoto Yamasaki, Tsuyoshi Takahashi, Yukinori Kurokawa, Kiyokazu Nakajima, Shuji Takiguchi, Masaki Mori, Yuichiro Doki

Erschienen in: World Journal of Surgery | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

There is no generally accepted treatment strategy for cervical cancer. The aim of this study was to evaluate the safety and efficacy of larynx-preserving limited resection with free jejunal graft for cervical esophageal cancer.

Methods

We retrospectively reviewed data of 58 patients with cervical esophageal cancer who underwent limited resection and free jejunal graft with or without laryngeal preservation. Among them, 45 patients received neoadjuvant treatment.

Results

Larynx-preserving surgery was conducted in 33 of the 58 patients (56.9 %). A higher proportion of patients who underwent laryngopharyngectomy with cervical esophagectomy (larynx-nonpreserving group) had cT4 tumors than those who underwent larynx-preserving cervical esophagectomy (larynx-preserving group) (72 vs. 12 %). The overall incidence of postoperative complications was similar in the two groups (56 vs. 52 %). The 5-year survival rate was 44.9 % for the entire group. Laryngeal preservation did not reduce overall survival compared with the larynx-nonpreserving operation (5-year survival rate: 57.8 vs. 25.8 %). Multivariate analysis identified the number of metastatic lymph nodes as the only independent prognostic factor.

Conclusions

The present study demonstrated that larynx-preserving limited resection with free jejunal graft is feasible. Also, this approach did not worsen the prognosis compared with the larynx-nonpreserving operation. Limited resection with free jejunal graft and laryngeal preservation is a promising treatment strategy for cervical esophageal cancer.
Literatur
1.
Zurück zum Zitat The Japan Esophageal Society (2011) Comprehensive registry of esophageal cancer in Japan, 2003. Esophagus 8:9–29CrossRef The Japan Esophageal Society (2011) Comprehensive registry of esophageal cancer in Japan, 2003. Esophagus 8:9–29CrossRef
2.
Zurück zum Zitat Yin WB, Zhang L, Miao Y et al (1983) The results of high-energy electron therapy in carcinoma of the esophagus compared with telecobalt therapy. Clin Radiol 34:393–406 Yin WB, Zhang L, Miao Y et al (1983) The results of high-energy electron therapy in carcinoma of the esophagus compared with telecobalt therapy. Clin Radiol 34:393–406
3.
Zurück zum Zitat Ott K, Lordick F, Molls M et al (2009) Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus. Br J Surg 96:258–266PubMedCrossRef Ott K, Lordick F, Molls M et al (2009) Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus. Br J Surg 96:258–266PubMedCrossRef
4.
Zurück zum Zitat Triboulet JP, Mariette C, Chevalier D et al (2001) Surgical management of carcinoma of the hypopharynx and cervical esophagus. Arch Surg 136:1164–1170PubMedCrossRef Triboulet JP, Mariette C, Chevalier D et al (2001) Surgical management of carcinoma of the hypopharynx and cervical esophagus. Arch Surg 136:1164–1170PubMedCrossRef
6.
Zurück zum Zitat Wang S, Liao Z, Chen Y et al (2006) Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience. J Thorac Oncol 1:252–259PubMed Wang S, Liao Z, Chen Y et al (2006) Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience. J Thorac Oncol 1:252–259PubMed
7.
Zurück zum Zitat NCCN (2011) National comprehensive cancer network clinical practice guidelines in oncology. National Comprehensive Cancer Network, Fort Washington NCCN (2011) National comprehensive cancer network clinical practice guidelines in oncology. National Comprehensive Cancer Network, Fort Washington
8.
Zurück zum Zitat Uno T, Isobe K, Kawakami H et al (2007) Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus. Dis Esophagus 20:12–18PubMedCrossRef Uno T, Isobe K, Kawakami H et al (2007) Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus. Dis Esophagus 20:12–18PubMedCrossRef
9.
Zurück zum Zitat Bidoli P, Bajetta E, Stani SC et al (2002) Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus. Cancer 94:352–361PubMedCrossRef Bidoli P, Bajetta E, Stani SC et al (2002) Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus. Cancer 94:352–361PubMedCrossRef
10.
Zurück zum Zitat Stuschke M, Stahl M, Wilke H et al (1999) Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical esophagus. Oncology 57:99–105PubMedCrossRef Stuschke M, Stahl M, Wilke H et al (1999) Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical esophagus. Oncology 57:99–105PubMedCrossRef
12.
Zurück zum Zitat Ferahkose Z, Bedirli A, Kerem M et al (2008) Comparison of free jejunal graft with gastric pull-up reconstruction after resection hypopharyngeal and cervical esophageal carcinoma. Dis Esophagus 21:340–345PubMedCrossRef Ferahkose Z, Bedirli A, Kerem M et al (2008) Comparison of free jejunal graft with gastric pull-up reconstruction after resection hypopharyngeal and cervical esophageal carcinoma. Dis Esophagus 21:340–345PubMedCrossRef
13.
Zurück zum Zitat Daiko H, Hayashi R, Saikawa M et al (2007) Surgical management of carcinoma of the cervical esophagus. J Surg Oncol 96:166–172PubMedCrossRef Daiko H, Hayashi R, Saikawa M et al (2007) Surgical management of carcinoma of the cervical esophagus. J Surg Oncol 96:166–172PubMedCrossRef
14.
Zurück zum Zitat Kadota H, Sakuraba M, Kimata Y et al (2009) Larynx-preserving esophagectomy and jejunal transfer for cervical esophageal carcinoma. Laryngoscope 119:1274–1280PubMedCrossRef Kadota H, Sakuraba M, Kimata Y et al (2009) Larynx-preserving esophagectomy and jejunal transfer for cervical esophageal carcinoma. Laryngoscope 119:1274–1280PubMedCrossRef
15.
Zurück zum Zitat Sobin LH, Wittekind C (2002) TNM classification of malignant tumours, 6th edn. Wiley, New York Sobin LH, Wittekind C (2002) TNM classification of malignant tumours, 6th edn. Wiley, New York
16.
Zurück zum Zitat Miyata H, Yamasaki M, Takiguchi S et al (2010) Prognostic value of endoscopic biopsy findings after induction chemoradiotherapy with and without surgery for esophageal cancer. Ann Surg 253:279–284CrossRef Miyata H, Yamasaki M, Takiguchi S et al (2010) Prognostic value of endoscopic biopsy findings after induction chemoradiotherapy with and without surgery for esophageal cancer. Ann Surg 253:279–284CrossRef
17.
Zurück zum Zitat Makino T, Miyata H, Yamasaki M et al (2010) Utility of response evaluation to neoadjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma. Surgery 148:908–918PubMedCrossRef Makino T, Miyata H, Yamasaki M et al (2010) Utility of response evaluation to neoadjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma. Surgery 148:908–918PubMedCrossRef
18.
Zurück zum Zitat Bergquist H, Ejenell H, Fogdestam I et al (2004) Functional long-term outcome of a free jejunal transplant reconstruction following chemoradiotherapy and radical resection for hypopharyngeal and proximal oesophageal carcinoma. Dig Surg 21:426–431PubMedCrossRef Bergquist H, Ejenell H, Fogdestam I et al (2004) Functional long-term outcome of a free jejunal transplant reconstruction following chemoradiotherapy and radical resection for hypopharyngeal and proximal oesophageal carcinoma. Dig Surg 21:426–431PubMedCrossRef
19.
Zurück zum Zitat Shirakawa Y, Naomoto Y, Noma K et al (2004) Free jejunal graft for hypopharyngeal and esophageal reconstruction. Langenbecks Arch Surg 389:387–390PubMedCrossRef Shirakawa Y, Naomoto Y, Noma K et al (2004) Free jejunal graft for hypopharyngeal and esophageal reconstruction. Langenbecks Arch Surg 389:387–390PubMedCrossRef
20.
Zurück zum Zitat Wang LS, Chu PY, Kuo KT et al (2006) A reappraisal of surgical management for squamous cell carcinoma in the pharyngoesophageal junction. J Clin Oncol 93:468–476 Wang LS, Chu PY, Kuo KT et al (2006) A reappraisal of surgical management for squamous cell carcinoma in the pharyngoesophageal junction. J Clin Oncol 93:468–476
21.
Zurück zum Zitat Jones AS, Roland NJ, Hamilton J et al (1992) Malignant tumors of the cervical esophagus. Clin Otolaryngol Allied Sci 21:49–53 Jones AS, Roland NJ, Hamilton J et al (1992) Malignant tumors of the cervical esophagus. Clin Otolaryngol Allied Sci 21:49–53
22.
Zurück zum Zitat Laterza E, Mosciaro O, Urso US et al (1994) Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy. Hepatogastroenterology 41:278–282PubMed Laterza E, Mosciaro O, Urso US et al (1994) Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy. Hepatogastroenterology 41:278–282PubMed
23.
Zurück zum Zitat Kelly DJ, Wolf R, Shaha AR et al (1995) Impact of clinicopathologic parameters on patient survival in carcinoma of the cervical esophagus. Am J Surg 170:427–431CrossRef Kelly DJ, Wolf R, Shaha AR et al (1995) Impact of clinicopathologic parameters on patient survival in carcinoma of the cervical esophagus. Am J Surg 170:427–431CrossRef
24.
Zurück zum Zitat Kakegawa T, Yamana H, Ando N (1985) Analysis of surgical treatment for carcinoma situated in the cervical esophagus. Surgery 97:150–157PubMed Kakegawa T, Yamana H, Ando N (1985) Analysis of surgical treatment for carcinoma situated in the cervical esophagus. Surgery 97:150–157PubMed
Metadaten
Titel
Larynx-Preserving Limited Resection and Free Jejunal Graft For Carcinoma of the Cervical Esophagus
verfasst von
Hiroshi Miyata
Makoto Yamasaki
Tsuyoshi Takahashi
Yukinori Kurokawa
Kiyokazu Nakajima
Shuji Takiguchi
Masaki Mori
Yuichiro Doki
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 3/2013
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-012-1875-7

Weitere Artikel der Ausgabe 3/2013

World Journal of Surgery 3/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.